Find information on thousands of medical conditions and prescription drugs.

Imperforate anus

An imperforate anus or anal atresia is a birth defect in which the rectum is malformed. Its cause is unknown. more...

ICF syndrome
Ichthyosis vulgaris
Imperforate anus
Inborn error of metabolism
Incontinentia pigmenti
Infant respiratory...
Infantile spinal muscular...
Infective endocarditis
Inflammatory breast cancer
Inguinal hernia
Interstitial cystitis
Iodine deficiency
Irritable bowel syndrome


There are several forms of imperforate anus:

  • A low lesion, in which the colon remains close to the skin. In this case, there may be a stenosis (narrowing) of the anus, or the anus may be missing altogether, with the rectum ending in a blind pouch.
  • A high lesion, in which the colon is higher up in the pelvis and there is a fistula connecting the rectum and the bladder, urethra or the vagina.
  • A cloaca (named after the analogous orifice in amphibians), where the rectum, vagina and colon are joined into a single opening.

Imperforate anus usually presents along with other birth defects—spinal problems, anal atresia, heart problems, tracheoesophageal fistula, esophageal atresia, renal anomalies, and limb anomalies.


Imperforate anus usually requires immediate surgery to open a passage for faeces. Depending on the severity of the imperforate, it is either treated with a perineal anoplasty or colostomy.


With a high lesion, many children have problems controlling bowel function and most also become constipated. With a low lesion, children generally have good bowel control, but they may still become constipated.


Imperforate anus has an estimated incidence of 1 in 5,000 live births. It is more common in boys than in girls.


[List your site here Free!]

Hyperthyroidism in pregnancy: achieve euthyroid status as early as possible
From OB/GYN News, 6/1/04 by Michele G. Sullivan

ALEXANDRIA, VA. -- Achieving euthyroid status as early in pregnancy as possible--and ideally, before conception--is crucial in preventing maternal and fetal complications from maternal hyperthyroidism.

Uncontrolled hyperthyroidism in pregnancy is rare, but its consequences are serious. Dr. Jorge Mestman said at a symposium sponsored by the American Thyroid Association.

The relative risk of prematurity can soar to as much as 16 times the rate seen in the general population if maternal hyperthyroidism isn't controlled during gestation. In addition, there are both a 9-fold increase in the relative risk of low birth weight and a 5-fold increase in the relative risk of severe preeclampsia. Central congenital hypothyroidism in the neonate is also a possible complication, said Dr. Mestman, director of the diabetes and metabolic diseases center at the University of Southern California in Los Angeles.

Severe, uncontrolled maternal hyperthyroidism may result in maternal congestive heart failure, thyroid storm, or placental abruption: the infant may be stillborn or have thyroid dysfunction.

The relative risks of these outcomes are still elevated--although not as dramatically--in women whose hyperthyroidism is controlled sometime during the pregnancy, he said at the symposium, which was also sponsored by the American Association of Clinical Endocrinologists.

Most women with poorly controlled or uncontrolled hyperthyroidism have preexisting conditions, such as Graves' disease or toxic adenoma. However, a hyperthyroidism of pregnancy called gestational transient thyrotoxicosis (GTT) occurs in as many as 15% of otherwise normal pregnancies. It is more common in women who are pregnant with multiples and is related to inappropriate secretion of HCG. This is a self-limited condition that needs no antithyroid medication.

The diagnosis of GTT is a clinical one, Dr. Mestman said; thyroid tests will show low serum TSH and a normal or elevated free [T.sub.4] level. Patients with Graves' disease will have had prepregnancy symptoms that will continue and perhaps increase during pregnancy; women with GTT will have had no prepregnancy symptoms. Nausea and vomiting can be significant for women with GTT but may be absent or mild in women with Graves' disease. Goiter, ophthalmopathy, and antithyroid peroxidase antibodies will be absent in women with GTT but present in women with Graves' disease.

Pregnant women with Graves' hyperthyroidism should be treated with antithyroid drugs; the target is to keep the free [T.sub.4] level in the upper one-third range of normal. [beta]-Blockers may be given to control the hypermetabolic symptoms that occur in hyperthyroidism. Women should be advised to avoid excessive physical activity that can exacerbate shortness of breath and increased heart rate. They should be carefully monitored for signs of preeclampsia.

Two antithyroid drugs are available: methimazole (MMI) and propylthiouracil (PTU), with PTU recommended for pregnant women. Although MMI offers the advantage of a longer half-life and, thus, single daily dosing, it has been associated with rare cases of congenital fetal abnormalities, including scalp defects and methimazole embryopathy. This constellation of defects can include choanal atresia, imperforate anus, esophageal atresia, and cardiovascular defects.

The usual dosage of PTU is 100-300 mg/day, divided into three doses. Follow the free [T.sub.4] level every 2-4 weeks. When it reaches the target level, decrease the PTU dosage to the minimum necessary to keep the free [T.sub.4] level in the upper one-third range of normal. If the TSH level rises or becomes detectable, the patient is probably getting too much antithyroid medication. When euthyroid status is achieved, the patient should begin gaining weight more easily and her pulse rate will decrease.

Fetuses whose mothers take excessive amounts of antithyroid drugs can be born with neonatal hypothyroidism and goiter. A high fetal heart rate, low growth rate, and evidence of goiter on ultrasound are indications of fetal hypothyroidism.

Both MMI and PTU are safe for use during lactation, but the maximum daily dose is lower: 200 mg/day of PTU and 20 mg/day of MMI.


Mid-Atlantic Bureau

COPYRIGHT 2004 International Medical News Group
COPYRIGHT 2004 Gale Group

Return to Imperforate anus
Home Contact Resources Exchange Links ebay